Cart
sales@molnova.com
4-Chloro-2-bromoacetophenone
CAS No. 536-38-9
4-Chloro-2-bromoacetophenone( —— )
Catalog No. M24520 CAS No. 536-38-9
4-Chloro-2'-bromoacetophenone against glycogen synthase kinase-3 (GSK-3beta).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 10MG | 68 | In Stock |
|
| 25MG | 115 | In Stock |
|
| 50MG | 173 | In Stock |
|
| 100MG | 258 | In Stock |
|
| 200MG | 388 | In Stock |
|
| 500MG | 642 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-Chloro-2-bromoacetophenone
-
NoteResearch use only, not for human use.
-
Brief Description4-Chloro-2'-bromoacetophenone against glycogen synthase kinase-3 (GSK-3beta).
-
Description4-Chloro-2'-bromoacetophenone against glycogen synthase kinase-3 (GSK-3beta).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetGSK-3
-
RecptorGSK-3β
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number536-38-9
-
Formula Weight233.49
-
Molecular FormulaC8H6BrClO
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC1=CC(=CC=C1C(=O)CBr)Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
GSK-3β inhibitor 11
GSK-3β inhibitor 11 (compound 21) is a potent glycogen synthase kinase-3β (GSK-3β) inhibitor with an IC50 of 10.02 μM, demonstrating potential utility in neurodegenerative disease research .
-
VAS2870
VAS2870 is a NADPH oxidase (NOX) inhibitor.
-
GSK-3β inhibitor 12
GSK-3β inhibitor 12 is a selective GSK-3β inhibitor.GSK-3β inhibitor 12 inhibits 49.11% of 25 μM GSK-3β activity and 37.11% of 50 μM GSK-3β activity.
